<Disease><Name>INFANTILE CEREBELLAR-RETINAL DEGENERATION (ICRD)</Name><Synonym /><OMIM><Number>614559</Number><URL>http://omim.org/entry/614559</URL></OMIM><Orphanet><Number>318850</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=318850</URL></Orphanet><Protein><Number>Aconitate hydratase, mitochondrial</Number><URL>https://www.uniprot.org/uniprot/Q99798</URL></Protein><ExPASy><Number>4.2.1.3</Number><URL>http://enzyme.expasy.org/EC/4.2.1.3</URL></ExPASy><Gene>22q13.2</Gene><ICD>E88.8</ICD><Summary>rare;autosomal recessive;mutation in the aconitase-2 gene</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2214</id><symptom>hyporeflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3357</id><symptom>muscle atrophy / muscular atrophy</symptom><category>MUSCLES</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3817</id><symptom>retinal dystrophy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1700</id><symptom>small for gestational age (SGA), intrauterine growth retardation (IUGR)</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1605</id><name>cis-Aconitic acid</name><specimen>urine</specimen><value /><min>3.80</min><max>95.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2061</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value /><min>0.00</min><max>50.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>2100</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value /><min>60.00</min><max>120.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>GCMS</method><comment /></metabolite><metabolite><id>2101</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value /><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>GCMS</method><comment /></metabolite><metabolite><id>2102</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value /><min>0.00</min><max>79.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>GCMS</method><comment /></metabolite><metabolite><id>1978</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value /><min>160.00</min><max>590.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1979</id><name>2-Oxoglutaric acid</name><specimen>urine</specimen><value /><min>2.00</min><max>17.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1870</id><name>Isocitric acid</name><specimen>urine</specimen><value /><min>20.40</min><max>89.20</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite></Metabolites><Literatures><literature><id>6415</id><title>Clinical, radiological, and genetic characteristics of 16 patients with ACO2 gene defects: Delineation of an emerging neurometa</title><author>Sharkia R,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>2</number><pages>264-275</pages><co_aut>et al.</co_aut></literature><literature><id>6419</id><title>Increased Survival and Partly Preserved Cognition in a Patient With ACO2-Related Disease Secondary to a Novel Variant</title><author>Srivastava S,</author><journal>J Child Neurol</journal><year>2017</year><book /><volume>32</volume><number>9</number><pages>840-845</pages><co_aut>et al.</co_aut></literature><literature><id>6420</id><title>Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiency</title><author>Abela L,</author><journal>PLoS One</journal><year>2017</year><book /><volume>12</volume><number>5</number><pages>e0176363</pages><co_aut>et al.</co_aut></literature><literature><id>6418</id><title>Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency</title><author>Sadat R,</author><journal>Mol Genet Metab</journal><year>2016</year><book /><volume>118</volume><number>1</number><pages>28-34</pages><co_aut>et al.</co_aut></literature><literature><id>6417</id><title>Mutations in the tricarboxylic acid cycle enzyme, aconitase 2, cause either isolated or syndromic optic neuropathy with encepha</title><author>Metodiev MD,</author><journal>J Med Genet</journal><year>2014</year><book /><volume>51</volume><number>12</number><pages>834-838</pages><co_aut>et al.</co_aut></literature><literature><id>6416</id><title>Infantile cerebellar-retinal degeneration associated with a mutation in mitochondrial aconitase, ACO2</title><author>Spiegel R,</author><journal>Am J Hum Genet</journal><year>2012</year><book /><volume>90</volume><number>3</number><pages>518-523</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>